Adverse events94

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 94

Type	Event	Organ system	Group	Affected	At risk	Events
other	Hyopokalaemia	Metabolism and nutrition disorders	Amikacin Fosfomycin Inhalation Solution	6	71	6
other	Hyopokalaemia	Metabolism and nutrition disorders	Aerosolized Placebo	6	72	8
other	Septic shock	Infections and infestations	Amikacin Fosfomycin Inhalation Solution	4	71	4
other	Septic shock	Infections and infestations	Aerosolized Placebo	7	72	7
other	Pneumonia	Infections and infestations	Amikacin Fosfomycin Inhalation Solution	5	71	5
other	Pneumonia	Infections and infestations	Aerosolized Placebo	5	72	5
other	Sepsis	Infections and infestations	Amikacin Fosfomycin Inhalation Solution	5	71	5
other	Sepsis	Infections and infestations	Aerosolized Placebo	4	72	4
other	Pleural effusion	Respiratory, thoracic and mediastinal disorders	Amikacin Fosfomycin Inhalation Solution	4	71	5
other	Pleural effusion	Respiratory, thoracic and mediastinal disorders	Aerosolized Placebo	5	72	6
other	Pneumothorax	Respiratory, thoracic and mediastinal disorders	Amikacin Fosfomycin Inhalation Solution	5	71	6
other	Pneumothorax	Respiratory, thoracic and mediastinal disorders	Aerosolized Placebo	2	72	2
other	Acute respiratory failure	Respiratory, thoracic and mediastinal disorders	Amikacin Fosfomycin Inhalation Solution	3	71	3
other	Acute respiratory failure	Respiratory, thoracic and mediastinal disorders	Aerosolized Placebo	2	72	2
other	Acute respiratory distress syndrome	Respiratory, thoracic and mediastinal disorders	Amikacin Fosfomycin Inhalation Solution	2	71	2
other	Acute respiratory distress syndrome	Respiratory, thoracic and mediastinal disorders	Aerosolized Placebo	2	72	2
other	Atelectasis	Respiratory, thoracic and mediastinal disorders	Amikacin Fosfomycin Inhalation Solution	2	71	4
other	Atelectasis	Respiratory, thoracic and mediastinal disorders	Aerosolized Placebo	2	72	2
other	Bronchospasm	Respiratory, thoracic and mediastinal disorders	Amikacin Fosfomycin Inhalation Solution	2	71	2
other	Bronchospasm	Respiratory, thoracic and mediastinal disorders	Aerosolized Placebo	2	72	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01969799/events

API reference For AI assistants

Adverse events94

Sources 3

Read this list from software.